glutathione epigenetic drug resistance

glutathione epigenetic drug resistance Novel therapeutic strategies and targets in cancer Cisplatin Resistance: Genetic and Epigenetic

Name: glutathione epigenetic drug resistance Novel therapeutic strategies and targets in cancer Cisplatin Resistance: Genetic and Epigenetic
Brand: reganhouse.co.nz
SKU: 94962540420
Price: 26.05 USD
Availability: InStock
Rating: 4.5382 (16 reviews)

Cisplatin Resistance: Genetic and Epigenetic Factors Involved Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis World Journal of Surgical Oncology Springer Nature Link A prismatic view of the epigenetic metabolic regulatory axis in breast cancer therapy resistance Oncogene Drug resistance mechanisms in cancers: Execution of pro survival strategies PMC Epigenetic plasticity in cancer drug resistance: mechanistic insights and strategies for therapeutic intervention Acta Pharmacologica Sinica The role of epigenetic modifications in drug resistance and treatment of breast cancer Cellular & Molecular Biology Letters Springer Nature Link

SKU: 94962540420 · From reganhouse.co.nz

4.5

USD26.05 USD65.05

Pay in 4 interest-free payments of $6.51 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

While numerous randomized clinical trials substantiate the antidepressant efficacy of Rhodiola, Ginkgo, and Ashwagandha, these investigations are frequently hindered by limited sample sizes, diverse dosing protocols, variability in extract standardization, and insufficient integration of mechanistic biomarkers

Explore our dark spots and pigmentation collection for complementary products

Find out in the Concerns and Cautions section of our NAC Supplements Review

BJT-778 showed the highest binding affinity to FcRI and FcRIIIa which was correlated with expression on cMono, iMono, and mDCs

First, peptides have proven clinical utility across multiple therapeutic areas, with particular success in endocrine, oncological, and rare disease applications